21 December 2017Big Pharma

Janssen-Cilag fined €25m over ‘smear campaign’ against generic rivals

France’s competition regulator has fined Johnson & Johnson and its subsidiary Janssen-Cilag €25 million ($29.7 million) for delaying generic versions of the pain drug Durogesic.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk